Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Advanced Breast Cancer Patients Treated With Oral Vinorelbine: a Prospective and Retrospective, Observational Study - VINOREAL

NCT06500494 is registered in ClinicalTrials.gov with Pierre Fabre Medicament as lead sponsor.

NCT NCT06500494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06500494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Advanced Breast Cancer Patients Treated With Oral Vinorelbine: a Prospective and Retrospective, Observational Study - VINOREAL
Lead sponsor
Pierre Fabre Medicament
Phase
Observational
Overall status
Active, not recruiting
Start date
September 10, 2024
Completion date
September 30, 2028
Enrollment
368 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

advanced breast cancer